Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cyteir Therapeutics Q2 EPS $(0.34) Up From $(4.83) YoY

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.34) per share. This is a 92.96 percent increase over losses of $(4.83) per share from the same period last year.
byBenzinga Newsdesk
August 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.34) per share. This is a 92.96 percent increase over losses of $(4.83) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts